Clinical Trials

Keywords/SWOG Study Number

Area of Research

Accrual Status

Any

Open

Closed

Limit to SWOG Trials

All Trials

SWOG Trials Only

Show only published studies

Study Type

Treatment

Study Chair

Participating Institution

Phase

Cancer Control Subcommittee

Study Sponsor

FDA Registration Trial

Uses PRO Forms

1033 Results

View

Status	Trial Number	Title Sort descending	Activated	Closed	Accrual	Phase	Published
Closed	SWOG-9343	Advanced Prostate	8/15/1994	1/15/1997	100%		Published
Closed	S0111	Advanced Prostate	6/15/2001	11/15/2003	100%		Published
Closed	S0032	Advanced Prostate	12/1/2001	6/1/2005	48%		Published
Closed	S0418	Advanced Prostate	4/1/2005	5/1/2006	62%		Published
Closed	S0421	Advanced Prostate	8/21/2006	5/1/2010	99%		Published
Closed	SWOG-9346	Advanced Prostate	5/15/1995	9/1/2008	88%		Published
Closed	S0354	Advanced Prostate	4/1/2007	5/15/2008	100%		Published
Closed	SWOG-9338	Advanced Renal	12/15/1994	9/1/1997	100%		Published
Closed	S0109	Advanced Renal	5/1/2001	2/1/2002	100%		Published
Closed	S0317	Advanced Renal	5/1/2003	12/15/2005	100%		Published
Closed	S0412	Advanced Renal	9/1/2004	5/15/2005	100%		Published
Closed	S0312	Advanced Renal	12/1/2004	8/15/2005	100%		Published
Closed	S0717	Advanced Renal	6/15/2008	4/1/2009	4%
Closed	S0007	Advanced, Recurrent, or Metastatic	11/1/2000	5/15/2003	100%		Published
Closed	S0226	ADVANCED: Anastrozole vs. Anastrozole and Fulvestrant	4/1/2004	7/1/2009	100%		Published
Closed	S0029	ADVANCED: Docetaxel for Metastatic Breast Cancer	8/1/2001	6/15/2005	34%
Closed	S0102	ADVANCED: Doxetaxel/Vinorelbine/Filgrastim for HER-2 Neg Stage IV Breast Cancer	5/1/2001	1/1/2004	100%		Published
Closed	S0338	ADVANCED: Imatinib Mesylate Plus Capecitabine for Stage IV Breast Cancer	6/15/2004	12/15/2005	39%		Published
Closed	S0511	ADVANCED: Male Breast Cancer	9/15/2005	1/10/2007	0%
Closed	S0622	ADVANCED: Phase II Dasatinib Treatment for Bone-Metastasis Predominant MBC	3/15/2007	12/15/2010	100%		Published